Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Electron Expects 7-Percent Revenue Growth in 2006; Leerink Swann Initiates Coverage

NEW YORK, Dec. 22 (GenomeWeb News) - Thermo Electron issued its financial guidance for 2006 today, expecting 16 percent growth in earnings and 7 percent on revenues.


Annual revenue for 2006 is expected to grow 7 percent, to between $2.78 billion and $2.83 billion, compared with the company's 2005 estimate of $2.61 billion to $2.63 billion.


The Waltham, Mass.-based company expects 2006 earnings per share of $1.75 to $1.80 before subtracting $.10 for stock option expensing during the year.


Marjin Dekkers, president and CEO, said the company expects "accelerated expansion" of its operating margins and that it will improve "well above 100 basis points for the year."


The guidance does not reflect any acquisitions or divestures the company may complete in 2006, but it does reflect the favorable impact from acquisitions completed in 2005 and expected organic growth of 4 percent to 5 percent, Thermo Electron said.


The company also affirmed its expected 2005 adjusted earnings guidance of $1.51 to $1.54 per share.


In separate news, investment bank Leerink Swann & Company initiated coverage of Thermo Electron with an "Outperform" rating today.


Senior biotechnology analyst John Sullivan cited Thermo Electron's global reach, new products, strong management, and execution as reasons for the rating.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.